Literature DB >> 6408661

Three-choice drug discrimination: phencyclidine-like stimulus effects of opioids.

J M White, S G Holtzman.   

Abstract

To assess the commonalities and differences in the discriminative stimulus properties of phencyclidine (PCP) and psychotomimetic opioids, rats were trained to discriminate PCP (2.0 mg/kg), cyclazocine (1.0 mg/kg), and saline in a three-choice discrete-trial avoidance paradigm. Stimulus control of behavior, defined as the reliable completion of 18 trials of a 20-trial session on the appropriate choice lever after administration of PCP, cyclazocine, or saline, was established in an average of 157 sessions. In tests of stimulus generalization, SKF-10,047 and dextrorphan engendered lever choices appropriate to both PCP and cyclazocine, sometimes in the same animal and at the same dose. The rats responded almost exclusively on the PCP-appropriate lever after ketamine and on the saline lever after morphine and d-amphetamine, indicating pharmacologic specificity. Naltrexone, in doses that had little effect on stimulus control of behavior by PCP, completely blocked cyclazocine-like stimulus control. Decreases in cyclazocine choices in the presence of naltrexone were associated with increases in PCP choices. These results support conclusions derived from two-choice procedures that psychotomimetic opioids have PCP-like stimulus effects, and provide direct evidence that these effects of cyclazocine are mediated by a component of action insensitive to an opiate antagonist.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408661     DOI: 10.1007/BF00427484

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Multiple opiate receptors: emerging concepts.

Authors:  R S Zukin; S R Zukin
Journal:  Life Sci       Date:  1981-12-28       Impact factor: 5.037

2.  Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites.

Authors:  R S Zukin; S R Zukin
Journal:  Mol Pharmacol       Date:  1981-09       Impact factor: 4.436

Review 3.  Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions.

Authors:  S Herling; J H Woods
Journal:  Life Sci       Date:  1981-04-06       Impact factor: 5.037

4.  Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone.

Authors:  H E Shannon; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1976-11-10       Impact factor: 4.530

5.  Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats.

Authors:  H E Shannon
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

6.  The discriminative stimulus properties of cyclazocine: generalization studies involving nalorphine, morphine and LSD.

Authors:  J A Rosecrans; W T Chance; R M Spencer
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-05

7.  Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey.

Authors:  S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Pentazocine, cyclazocine, and nalorphine as discriminative stimuli.

Authors:  I D Hirschhorn
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

9.  Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film.

Authors:  R Quirion; R P Hammer; M Herkenham; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

10.  Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats.

Authors:  K T Brady; R L Balster; E L May
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

View more
  10 in total

1.  Drug discrimination procedures: differential characteristics of the drug A vs drug B and the drug A vs drug B vs no drug cases.

Authors:  M D Swedberg; T U Järbe
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.

Authors:  I P Stolerman; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  Effects of prior saline-morphine discrimination by pigeons on three-way discrimination including two morphine doses.

Authors:  D V Gauvin; A M Young
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Examining the reinforcement-enhancement effects of phencyclidine and its interactions with nicotine on lever-pressing for a visual stimulus.

Authors:  Natashia Swalve; Scott T Barrett; Rick A Bevins; Ming Li
Journal:  Behav Brain Res       Date:  2015-05-27       Impact factor: 3.332

5.  Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats.

Authors:  Joseph H Porter; Adam J Prus; Robert E Vann; Stephen A Varvel
Journal:  Psychopharmacology (Berl)       Date:  2004-08-13       Impact factor: 4.530

7.  Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure.

Authors:  P M Callahan; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 8.  Human drug discrimination: A primer and methodological review.

Authors:  B Levi Bolin; Joseph L Alcorn; Anna R Reynolds; Joshua A Lile; Craig R Rush
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

9.  Discriminable effects of phencyclidine analogs evaluated by multiple drug (PCP versus OTHER) discrimination training.

Authors:  D A Overton; C F Shen; G Y Ke; L P Gazdick
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

10.  1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs.

Authors:  E Weber; M Sonders; M Quarum; S McLean; S Pou; J F Keana
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.